Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors

• Zsófia Kutil,
• Jana Mikešová,
• Matthes Zessin,
• Marat Meleshin,
• Zora Nováková,
• Glenda Alquicer,
• Alan Kozikowski,
• Wolfgang Sippl,
• Cyril Bařinka,
• Mike Schutkowski

Affiliations

Zsófia Kutil

Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic

Jana Mikešová

Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic

Matthes Zessin

Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle, Germany

Marat Meleshin

Department of Enzymology, Institute of Biochemistry and Biotechnology, Charles Tanford Protein Centre, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

Zora Nováková

Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic

Glenda Alquicer

Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic

Alan Kozikowski

StarWise Therapeutics LLC, Madison, Wisconsin, United States

Wolfgang Sippl

Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle, Germany

Cyril Bařinka

Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic

Mike Schutkowski

Department of Enzymology, Institute of Biochemistry and Biotechnology, Charles Tanford Protein Centre, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany